Literature DB >> 21764467

Anti-tumor necrosis factor α treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis.

Georgia Avgerinou, Dimitris Tousoulis, Gerasimos Siasos, Evaggelos Oikonomou, Konstantinos Maniatis, Nikolaos Papageorgiou, Theodoros Paraskevopoulos, Antigoni Miliou, Dimitra Koumaki, George Latsios, Anastasia Therianiou, Athanasios Trikas, Anna Maria Kampoli, Christodoulos Stefanadis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21764467     DOI: 10.1016/j.ijcard.2011.06.112

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  18 in total

Review 1.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Giao Do; Camille Hua; Canelle Mazaud; Catherine Droitcourt; Carolyn Hughes; John R Ingram; Luigi Naldi; Olivier Chosidow; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2017-12-22

Review 2.  Metabolic Messengers: tumour necrosis factor.

Authors:  Jaswinder K Sethi; Gökhan S Hotamisligil
Journal:  Nat Metab       Date:  2021-10-14

Review 3.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Liz Doney; Corinna Dressler; Camille Hua; Carolyn Hughes; Luigi Naldi; Sivem Afach; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2022-05-23

Review 4.  Endothelial Dysfunction in Psoriasis: An Updated Review.

Authors:  Panagiota Anyfanti; Anastasia Margouta; Kyriakos Goulas; Maria Gavriilaki; Elizabeth Lazaridou; Aikaterini Patsatsi; Eugenia Gkaliagkousi
Journal:  Front Med (Lausanne)       Date:  2022-06-10

Review 5.  Does treatment of psoriasis reduce the risk of cardiovascular disease?

Authors:  Sarah Churton; Liza Brown; Thuzar M Shin; Neil J Korman
Journal:  Drugs       Date:  2014-02       Impact factor: 9.546

Review 6.  Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance.

Authors:  Evangelos Oikonomou; Konstantinos Mourouzis; Petros Fountoulakis; Georgios Angelos Papamikroulis; Gerasimos Siasos; Alexis Antonopoulos; Georgia Vogiatzi; Sotiris Tsalamadris; Manolis Vavuranakis; Dimitris Tousoulis
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

Review 7.  Do anti-tumour necrosis factor-α biologics affect subclinical measures of atherosclerosis and arteriosclerosis? A systematic review.

Authors:  Laurence Knowles; Nida Nadeem; Philip J Chowienczyk
Journal:  Br J Clin Pharmacol       Date:  2020-03-08       Impact factor: 4.335

Review 8.  Psoriasis: Comorbidities.

Authors:  Fumikazu Yamazaki
Journal:  J Dermatol       Date:  2021-03-25       Impact factor: 4.005

9.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Liz Doney; Corinna Dressler; Camille Hua; Carolyn Hughes; Luigi Naldi; Sivem Afach; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2021-04-19

Review 10.  Anti-inflammatory and Immunomodulatory Therapies in Atherosclerosis.

Authors:  Justine Deroissart; Florentina Porsch; Thomas Koller; Christoph J Binder
Journal:  Handb Exp Pharmacol       Date:  2022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.